Suzuki A. The "silent threat" of nocturnal hypoxia remains unresolved for patients with fibrotic interstitial lung diseases.
ERJ Open Res 2024;
10:01017-2023. [PMID:
38348239 PMCID:
PMC10860205 DOI:
10.1183/23120541.01017-2023]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2023] [Accepted: 12/19/2023] [Indexed: 02/15/2024] Open
Abstract
Nocturnal hypoxia has a significant impact on prognosis in patients with fibrotic interstitial lung diseases https://bit.ly/3RNzNVu.
Collapse